Showing results (1-10 of 367) with videos related to
Sort By:
Pageof 37
Nature Reviews. Nephrology|September 15, 2019
FGF23 at the crossroads of phosphate, iron economy and erythropoiesisDaniel Edmonston, Myles WolfNature Reviews. Cardiology|July 14, 2023
FGF23 and klotho at the intersection of kidney and cardiovascular diseaseDaniel Edmonston, Alexander Grabner, Myles WolfJournal of the American Heart Association|August 23, 2023
Plasma Serotonin and Cardiovascular Outcomes in Chronic Kidney DiseaseDaniel Edmonston, Tamara Isakova, Myles Wolf, et al.Journal of the American Society of Nephrology : JASN|March 12, 2026
Cardiovascular Outcomes among New Users of GLP-1 Receptor Agonists Compared with DPP-4 Inhibitors and Sulfonylureas in Kidney FailureBenjamin Catanese, Cameron Miller, Myles Wolf, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 7, 2024
Klotho and Clinical Outcomes in CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) StudyDaniel Edmonston, Michaela A A Fuchs, Emily J Burke, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 26, 2019
Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKDDaniel Edmonston, Daniel Wojdyla, Rupal Mehta, et al.Transactions of the American Clinical and Climatological Association|September 13, 2023
FGF23 AND ALTERED MINERAL HOMEOSTASIS IN KIDNEY DISEASE AND FOLLOWING INTRAVENOUS IRONMyles WolfAcademic Medicine : Journal of the Association of American Medical Colleges|November 15, 2002
Clinical research career development: the individual perspectiveMyles WolfKidney International|May 25, 2012
Update on fibroblast growth factor 23 in chronic kidney diseaseMyles WolfJournal of the American Society of Nephrology : JASN|May 29, 2010
Forging forward with 10 burning questions on FGF23 in kidney diseaseMyles WolfPageof 37